| DMF号:
20525 |
项目状态:A |
项目类型:II |
提交日期:2007-05-11 |
| 项目名称:IBANDRONATE SODIUM AS MANUFACTURED IN ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
20595 |
项目状态:A |
项目类型:II |
提交日期:2007-06-08 |
| 项目名称:ALFUZOSIN HYDROCHLORIDE AS MANUFACTURED IN ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21199 |
项目状态:A |
项目类型:II |
提交日期:2007-12-21 |
| 项目名称:MEMANTINE HYDROCHLORIDE AS MANUFACTURED IN ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21393 |
项目状态:A |
项目类型:II |
提交日期:2008-03-05 |
| 项目名称:PERINDOPRIL TERT-BUTYLAMINE AS MANUFACTURED BY APOTEX PHARMACHEM INC IN ONTARIO, CANADA AND APOTEX PHARMACHEM INDIA PVT LTD IN BANGALORE, INDIA FOR APOTEX PHARMACHEM INC |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21440 |
项目状态:A |
项目类型:II |
提交日期:2008-03-18 |
| 项目名称:PAROXETINE HYDROCHLORIDE ANHYDROUS USP (PAX) AS MANUFACTURED BY SIGNA SA DE CV IN TOLUCA, MEXICO; SRINI PHARMACEUTICALS LTD IN ANDHRA PRADESH, INDIA; APOTEX PHARMACHEM INC IN BRANTFORD, CANADA FOR APOTEX PHARMACHEM INC |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21574 |
项目状态:A |
项目类型:II |
提交日期:2008-04-29 |
| 项目名称:ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE AS MANUFACTURED IN BRANTFORD, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21819 |
项目状态:A |
项目类型:II |
提交日期:2008-07-18 |
| 项目名称:RISEDRONATE SODIUM HEMIPENTAHYDRATE AS MANUFACTURED IN ONTARIO, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21912 |
项目状态:A |
项目类型:II |
提交日期:2008-08-28 |
| 项目名称:PANTOPRAZOLE SODIUM SESQUIHYDRATE USP AS MANUFACTURED IN BRANTFORD, ONTARIO, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
21980 |
项目状态:A |
项目类型:II |
提交日期:2008-09-17 |
| 项目名称:OLANZAPINE AS MANUFACTURED IN BRANTFORD ON, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
22252 |
项目状态:A |
项目类型:II |
提交日期:2008-12-04 |
| 项目名称:RIVASTIGMINE TARTRATE AS MANUFACTURED IN BRANTFORD ON, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
22509 |
项目状态:A |
项目类型:II |
提交日期:2009-02-06 |
| 项目名称:CEVIMELINE HYDROCHLORIDE HEMIHYDRATE |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
22572 |
项目状态:A |
项目类型:II |
提交日期:2009-02-25 |
| 项目名称:ZALEPLON AS MANUFACTURED IN BRANTFORD ON CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
23079 |
项目状态:A |
项目类型:II |
提交日期:2009-08-28 |
| 项目名称:SUMATRIPTAN SUCCINATE USP AS MANUFACTURED IN BRANTFORD ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
23326 |
项目状态:A |
项目类型:II |
提交日期:2009-12-01 |
| 项目名称:ANASTROZOLE USP AS MANUFACTURED IN ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
23490 |
项目状态:A |
项目类型:II |
提交日期:2010-01-28 |
| 项目名称:LUBIPROSTONE AS MANUFACTURED IN ONTARIO CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
|
|
| DMF号:
23746 |
项目状态:A |
项目类型:II |
提交日期:2010-04-26 |
| 项目名称:RASAGILINE MESYLATE AS MANUFACTURED IN BANGALORE, INDIA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
24031 |
项目状态:A |
项目类型:II |
提交日期:2010-08-05 |
| 项目名称:WARFARIN POTASSIUM ISOPROPANOL SOLVATE |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
24266 |
项目状态:A |
项目类型:II |
提交日期:2010-10-08 |
| 项目名称:SITAGLIPTIN PHOSPHATE MONOHYDRATE AS MANUFACTURED IN BRANTFORD ON, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
24434 |
项目状态:A |
项目类型:II |
提交日期:2010-12-08 |
| 项目名称:VALGANCICLOVIR HYDROCHLORIDE USP AS MANUFACTURED IN KARNATAKA INDIA FOR APOTEX PHARMACHEM INC |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
25777 |
项目状态:A |
项目类型:II |
提交日期:2012-02-13 |
| 项目名称:DESVENLAFAXINE SUCCINATE MONOHYDRATE AS MANUFACTURED IN BRANTFORD ONTARIO, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
26150 |
项目状态:A |
项目类型:II |
提交日期:2012-02-08 |
| 项目名称:ROSUVASTATIN CALCIUM (ROS) AS MANUFACTURED IN BRANTFORD ONTARIO, CANADA AND TOLUCA ESTADO DE, MEXICO FOR APOTEX PHARMACHEM INC |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
|
|
| DMF号:
26631 |
项目状态:A |
项目类型:II |
提交日期:2013-01-22 |
| 项目名称:ERLOTINIB HYDROCHLORIDE AS MANUFACTURED IN ONTARIO, CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
| DMF号:
26824 |
项目状态:A |
项目类型:II |
提交日期:2013-08-23 |
| 项目名称:DARIFENACIN HYDROBROMIDE AS MANUFACTURED IN ONTARIO,CANADA |
| 项目持有人:
APOTEX PHARMACHEM INC
|
|
共有 55条记录， 3页，显示26-50 上一页 1 2 3 下一页
|
